Flagship Biosciences Revenue and Competitors

Denver, CO USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Flagship Biosciences's estimated annual revenue is currently $15.5M per year.(i)
  • Flagship Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Flagship Biosciences has 100 Employees.(i)
  • Flagship Biosciences grew their employee count by -4% last year.

Flagship Biosciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
VP Computational and Imaging ScienceReveal Email/Phone
4
VP, Lab OperationsReveal Email/Phone
5
VP, Clinical DiagnosticsReveal Email/Phone
6
VP Business DevelopmentReveal Email/Phone
7
VP, Sales & MarketingReveal Email/Phone
8
Sr. Director, Information TechnologyReveal Email/Phone
9
Chief Scientific OfficerReveal Email/Phone
10
Director Neurobiology and InflammationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M110%N/AN/A
#2
$2.8M1813%N/AN/A
#3
$70.2M453-1%N/AN/A
#4
$1.6M10-66%N/AN/A
#5
$3.7M24-8%N/AN/A
#6
$2.9M3728%N/AN/A
#7
$3.1M2025%N/AN/A
#8
$2.5M16-20%N/AN/A
#9
$9.1M590%N/AN/A
#10
$4.2M27-7%N/AN/A
Add Company

What Is Flagship Biosciences?

Flagship Biosciences was created by industry leading molecular pathologists to fill the growing need for advanced digital technology in drug development and medical devices. Our pathologists deliver quantitative results so our customers can make efficacy and toxicology assessments faster. We help our clients in many ways: Develop histology and IHC biomarkers Quantitate efficacy and toxicity tissue assays Increase visibility between study sponsors and their CROs Facilitate partnerships in clinical development

keywords:N/A

N/A

Total Funding

100

Number of Employees

$15.5M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Flagship Biosciences News

2022-04-20 - Moderna Co-founder Afeyan Discusses Entrepreneurship Philosophy

Noubar Afeyan, founder of Flagship Pioneering, spoke at an event hosted by the ... Codiak BioSciences, Rubius Therapeutics and many others.

2022-04-06 - Microbiome biotech Kaleido Biosciences shutters amid cash crunch ...

Kaleido Biosciences, formed by Flagship Pioneering as part of a wave of biotech companies developing microbiome therapies, has laid off its...

2022-04-06 - Kaleido Biosciences Culls Staff, Prepares to Cease Operations

Published: Apr 08, 2022 By Alex Keown. Layoffs/GettyStock. Shares of Kaleido Biosciences, a microbiome-focused company backed by Flagship Biosciences,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A10067%N/A
#2
$27.3M1019%N/A
#3
$24.7M1014%N/A
#4
$7.5M102-33%N/A
#5
N/A10292%N/A